Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $269.45 | Total: $1,347.25 |
| 1 | 10 | $228.24 | Total: $2,282.40 |
| 1 | 25 | $193.37 | Total: $4,834.25 |
| 1 | 50 | $164.84 | Total: $8,242.00 |
| 1 | 100 | $142.65 | Total: $14,265.01 |
Overview
Vamicamide (FK 176) is a novel anticholinergic compound. Vamicamide increases spontaneous locomotor activity in mice at 32 mgkg (p.o.) or higher and inhibits cataleptic convulsions in mice at 100 mgkg.
Chemical Properties
| Molecular Formula | C18H23N3O |
| Molecular Weight | 297.39 |
| CAS Numbers | 132373-81-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@@](C[C@H](N(C)C)C)(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Yamamoto T,et al. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45[12] 1274-84.